UB Paderborn / Katalog / Suche / in CDI

Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT

American journal of hematology, 2023-11, Vol.98 (11), p.1685-1698

2023

Link zum Volltext

Verfügbarkeit prüfen

S174: MYELOID NGS ANALYSES OF PAIRED SAMPLES FROM BONE MARROW AND PERIPHERAL BLOOD YIELD CONCORDANT RESULTS: A PROSPECTIVE COHORT ANALYSIS OF THE AGMT STUDY GROUP

HemaSphere, 2023-08, Vol.7 (S3), p.e3689035-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group

Cancers, 2023-04, Vol.15 (8), p.2305

2023

Link zum Volltext

Verfügbarkeit prüfen

Some remarks concerning the spaces of multipliers and convolutors, O^sub M^ and O'^sub C^, of Laurent Schwartz

Revista de la Real Academia de Ciencias Exactas, Físicas y Naturales. Serie A, Matemáticas, 2012-09, Vol.106 (2), p.407

Larcher, Julian

2012

Link zum Volltext

Verfügbarkeit prüfen

Some remarks concerning the spaces of multipliers and convolutors, $${\mathcal{O}_M}$$ and $${\mathcal{O}'_C}$$ , of Laurent Schwartz

Revista de la Real Academia de Ciencias Exactas, Físicas y Naturales. Serie A, Matemáticas, 2012-09, Vol.106 (2), p.407-417

Larcher, Julian

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 resultsResearch in context

EClinicalMedicine, 2024-01, Vol.67, p.102404

2024

Link zum Volltext

Verfügbarkeit prüfen

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

The Lancet infectious diseases, 2020-10, Vol.20 (10), p.1193-1203

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

The Lancet infectious diseases, 2023-10, Vol.23 (10), p.1186-1196

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2023-06, Vol.401 (10394), p.2138-2147

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Single-Arm “Window-of-Opportunity” Study of a Combination of Obinutuzumab and Venetoclax in Early Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - First Results of the AGMT NHL15B Study

Blood, 2020-11, Vol.136 (Supplement 1), p.26-26

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2023-05, Vol.29 (10), p.1887

2023

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

The Lancet. Haematology, 2021-02, Vol.8 (2), p.e135-e148

2021

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Subtypes in Patients Aged 70 Years and Older

Cancer investigation, 2016-05, Vol.34 (5), p.197-204

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results

EClinicalMedicine, 2024-01, Vol.67, p.102404-102404, Article 102404

2024

Link zum Volltext

Verfügbarkeit prüfen

Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial

Journal of geriatric oncology, 2022-06, Vol.13 (5), p.662-666

2022

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin/5-FU (CF) +/- panitumumab (P) for patients (pts) with non-resectable, advanced, or metastatic esophageal squamous cell cancer (ESCC): An open-label, randomized AIO/TTD/BDGO/EORTC phase III trial (POWER)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4011-4011

2017

Link zum Volltext

Verfügbarkeit prüfen

Making decisions to limit treatment in life-limiting and life-threatening conditions in children: a framework for practice

Archives of Disease in Childhood, 2015-05, Vol.100 (Suppl 2), p.s1-s23

2015

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids

Frontiers in microbiology, 2023-11, Vol.14, p.1320856-1320856

2023

Link zum Volltext

Verfügbarkeit prüfen

A controlled CO2 release experiment in a fault zone at the In-Situ Laboratory in Western Australia

International journal of greenhouse gas control, 2020-08, Vol.99, p.103100, Article 103100

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT

S174: MYELOID NGS ANALYSES OF PAIRED SAMPLES FROM BONE MARROW AND PERIPHERAL BLOOD YIELD CONCORDANT RESULTS: A PROSPECTIVE COHORT ANALYSIS OF THE AGMT STUDY GROUP

Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group

Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT

Some remarks concerning the spaces of multipliers and convolutors, O^sub M^ and O'^sub C^, of Laurent Schwartz

Some remarks concerning the spaces of multipliers and convolutors, $${\mathcal{O}_M}$$ and $${\mathcal{O}'_C}$$ , of Laurent Schwartz

A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 resultsResearch in context

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Phase II Single-Arm “Window-of-Opportunity” Study of a Combination of Obinutuzumab and Venetoclax in Early Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - First Results of the AGMT NHL15B Study

The EQ-5D-5L Predicts Treatment Outcomes and Provides Added Value to the R-IPSS in Patients with MDS, CMML or AML Treated within the Austrian Azacitidine Registry - a Prospective Cohort Study By the AGMT Study Group

Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer

Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial

Peripheral Blood Complete Remission Provides Added Value to the Classical Definition of Morphologic Complete Remission - a Prospective Cohort Study of 1441 Patients with MDS, CMML and AML Treated within the Austrian Azacitidine Registry

Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study

Breast Cancer Subtypes in Patients Aged 70 Years and Older

A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results

Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial

Cisplatin/5-FU (CF) +/- panitumumab (P) for patients (pts) with non-resectable, advanced, or metastatic esophageal squamous cell cancer (ESCC): An open-label, randomized AIO/TTD/BDGO/EORTC phase III trial (POWER)

Making decisions to limit treatment in life-limiting and life-threatening conditions in children: a framework for practice

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids

A controlled CO2 release experiment in a fault zone at the In-Situ Laboratory in Western Australia

Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project)

Aktive Filter

Suchergebnisse filtern